Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-01-12Clinical Trial Update: Management of Eczema by Specific Probiotic Strains [Phase 3]
Phase 3 trial evaluating management of eczema using specific probiotic strains has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-20Clinical Trial Update: 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis [Phase 1]
A Phase 1 trial evaluating a 0.005% sodium hypochlorite final rinse solution for atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families [NA]
The clinical trial 'A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families' has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-12Clinical Trial Update: Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy [Phase 4]
A Phase 4 clinical trial evaluating concurrent Altabax (retapamulin) with topical low-potency corticosteroids versus corticosteroid monother…
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis [Phase 4]
A Phase 4 long-term safety trial evaluating tacrolimus ointment for atopic dermatitis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients [NA]
The clinical trial evaluating pioglitazone for skin barrier function in atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-27Clinical Trial Update: Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects [Phase 3]
A Phase 3 pediatric trial evaluating Product 0405 versus vehicle control for mild-to-moderate atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-27Clinical Trial Update: Study to Determine the Pharmacokinetics of Product 0405 [Phase 3]
A Phase 3 pharmacokinetics study of Product 0405 sponsored by Fougera Pharmaceuticals Inc. for Atopic Dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-27Clinical Trial Update: Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects [Phase 3]
A Phase 3 study evaluating Product 0405 versus vehicle control for mild-to-moderate atopic dermatitis in pediatric patients has been withdra…
-
CLINICAL_TRIALS withdrawal · 2014-01-22Clinical Trial Update: Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) [Phase 1]
Phase 1 safety trial of the MVA Smallpox Vaccine in people with a history of atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-13Clinical Trial Update: Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis [NA]
A Bayer-sponsored clinical trial evaluating a new topical formulation for atopic dermatitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-07-21Clinical Trial Update: the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy [NA]
A clinical trial evaluating probiotics for atopic dermatitis in individuals with cow milk allergy has been withdrawn, with no results report…
-
CLINICAL_TRIALS withdrawal · 2011-06-07Clinical Trial Update: CT 327 in the "Atopy Patch Test" Model [Phase 1]
Phase 1 trial CT 327 for atopic dermatitis using the Atopy Patch Test model has been withdrawn.
-
EMA withdrawal · 2008-10-29EMA Withdrawn: Protopy (tacrolimus) — Astellas Pharma GmbH
Protopy (tacrolimus) has been withdrawn from the market in the European Union.